Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.40
-0.10 (-0.16%)
Aug 19, 2026, 9:58 AM CST

Shine-On BioMedical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
50.6230-9.52--
Revenue Growth
68.72%-----
Gross Profit
50.6230-6.67--
Operating Income
-195.93-125.5-136.07-62.68-18.61-11.5
Net Income
-181.72-110.29-118.89-37.17-19.54-11.24
Earnings Per Share
-3.63-2.21-2.39-0.75-0.43-0.61
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
808.81922.171,0441,1371,166905.98
Total Debt
-1.362.60.541.522.48
Net Cash (Debt)
808.81920.811,0411,1361,165903.5
Net Cash Growth
-12.16%-11.55%-8.40%-2.42%28.90%-
Net Cash Per Share
16.1718.4520.9022.8225.6548.91

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-143.38-114.75-91.45-26.88-21.66-8.46
Capital Expenditures
-0.04-0.03-0.11-0.07-0.48-2.25
Free Cash Flow
-143.42-114.78-91.56-26.95-22.14-10.71
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%-70.00%--
Operating Margin
-387.09%-418.33%--658.16%--
Pretax Margin
-358.95%-368.06%--366.82%--
Profit Margin
-359.00%-367.62%--390.23%--
FCF Margin
-283.34%-382.59%--282.94%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
62.48116.20-362.89--